Companion Diagnostics
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock insights into the global companion diagnostics market. Stay ahead with critical regulatory updates, investment trends, and strategic partnerships.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Companion Diagnostics hub for FDA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
Labcorp Launches FDA-Approved PD-L1 Companion Diagnostic for KEYTRUDA Ovarian Cancer Treatment
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.